Periodic Reporting for period 1 - Endoprotease 40 (E40) (First ever preventive treatment for celiac disease and gluten sensitivity)

Gluten ingestion triggers symptoms in people suffering Celiac Disease and Non-Celiac Gluten Sensitivity (CD & NCGS).CD affects 1-1.5% of the global population and NCGS 7-10%. Diagnosis rates are increasing, having increased on average 7.5%/year over the past decade and a...